INNOVADERM CRO IS NOW INDERO.

“Clinical Development Strategy that Patients Need and Investors Want” by Dr. Jasmina Jankicevic

Indero

Indero

Team of Experts

Author picture

Innovaderm is thrilled to announce that our team was present at the AID Dermatology Summit in San Francisco on January 7th!

Our very own Chief Medical Officer, Dr. Jasmina Jankicevic, delivered an insightful presentation titled “Clinical Development Strategy that Patients Need and Investors Want”.

Dr. Jankicevic’s talk was nothing short of incredible, shedding light on the intersection of patient needs and investor interests in clinical development. We are proud to be part of such important conversations. Listen to the full presentation below.

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.